World Journal of Endocrine Surgery

Register      Login

VOLUME 2 , ISSUE 1 ( January-April, 2010 ) > List of Articles

REVIEW ARTICLE

Is Prophylactic Central Compartment Lymph Node Dissection Necessary for Papillary Thyroid Carcinoma?

Gerard M Doherty, Travis J McKenzie, Joseph B Lillegard, Clive S Grant, Ian D Hay, James E Fisher, Geoffrey B Thompson

Citation Information : Doherty GM, McKenzie TJ, Lillegard JB, Grant CS, Hay ID, Fisher JE, Thompson GB. Is Prophylactic Central Compartment Lymph Node Dissection Necessary for Papillary Thyroid Carcinoma?. World J Endoc Surg 2010; 2 (1):1-7.

DOI: 10.5005/jp-journals-10002-1013

Published Online: 01-04-2010

Copyright Statement:  Copyright © 2010; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

The need for prophylactic central compartment lymph node dissection in patients with papillary thyroid carcinoma continues to be a subject of ongoing debate. Regional lymph node metastases are a common finding with papillary thyroid carcinoma, with an incidence as high as 50% or more. With the widespread use of high resolution ultrasound and sensitive thyroglobulin assays, lymph node metastases, not appreciated at the time of surgery, are showing up in the follow-up period, creating significant angst amongst patients, endocrinologists, and their surgeons. It was previously thought that lymph node metastases in papillary thyroid carcinoma had little bearing on survival, but this has more recently been challenged. Opponents of prophylactic central compartment node dissection cite high perioperative morbidity as a word of caution in performing prophylactic central neck dissections. The following review will look at the most up-to-date literature and best evidence for arriving at logical and sensible recommendations. This review will also look at specific definitions of what is a central compartment lymph node dissection. In the hands of experienced thyroid surgeons, prophylactic central compartment lymph node dissection, performed in a meticulous manner, can limit persistent or recurrent disease in the central compartment, and can diminish the need for routine administration of radioactive iodine, with acceptable perioperative morbidit


PDF Share
  1. Cancer statistics. Cancer J Clin 2008 Mar-Apr;58(2):71-96. Epub 2008 Feb 20.
  2. Thyroid cancer nodal metastases: Biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996;5:43-63.
  3. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997;82:1638-41.
  4. Lymph node metastasis from 259 papillary thyroid microcarcinomas: Frequency, pattern of occurrence and recurrence, and optical strategy for neck dissection. Ann Surg 2003;237:399-407.
  5. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999;23:970-73.
  6. Nodal Yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005;138:1095-100.
  7. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978-96.
  8. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63.
  9. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22-28.
  10. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-95.
  11. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-58.
  12. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-22.
  13. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-24
  14. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
  15. The implication of lymph node metastasis on survival in patients with welldifferentiated thyroid cancer. Am Surg 2005;71:731-34.
  16. Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer. 2006;106:524-31.
  17. A single recombinant human thyrotropinstimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 2005;90:5047-57.
  18. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214.
  19. A vision for the surgical management of papillary thyroid carcinoma: Extensive lymph node compartmental dissections and selective use of radioiodine. J Clin Endocrinol Metab 2009;94:1086-88.
  20. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002;131:249-56.
  21. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998;85:252-54.
  22. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004;139:43-45.
  23. Thyroid gland. In: Mulholland MW, Lillemoe KD, Doherty GM, et al (Eds). Greenfield's Surgery: Scientific Principles and Practice (4th ed). Philadelphia, Lippincott Williams and Wilkins 2006;1289-1309.
  24. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19:1153-58.
  25. Value of preoperative ultrasonography in surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006;141:489-94.
  26. Surgeon performed ultrasound in the management of thyroid malignancy. Am Surg 2004;70:576-80.
  27. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998;29:4-10.
  28. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2006;31:895-904.
  29. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996;20:854-59.
  30. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559-67.
  31. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003;113:2102-07.
  32. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000;166:29-33.
  33. Papillary thyroid carcinoma: Modified radical neck dissection improves prognosis. Arch Surg 1998;133:276-80.
  34. Thyroid cancer: The case for total thyroidectomy. Eur J Cancer Clin Oncol 1998;24:305-13.
  35. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: A 20-year review. Am Surg 1993;59:110-14.
  36. Complications of thyroid surgery: Analysis of a multicentric study on 14, 934 patients operated on in Italy over 5 years. World J Surg 2004;28:271-76.
  37. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Arch Surg 1998;338:167-69.
  38. Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 2003;197: 182-90.
  39. The risks and adequacy of an optimized surgical approach to the primary surgical management of PTC treated during 1999-2006.
  40. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140:1000-05.
  41. Papillary carcinoma of the thyroid. Otolaryngol Head and Neck Surg 1995;113:356-63.
  42. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Surgery 2009;145:514-18.
  43. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 2008;37:457-80.
  44. Concise review: Treatment for thyroid cancer as a risk factor for a second malignancy. Clin Thyroidol (online) 2008 20(2):3-4.
  45. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003;89:1638-44.
  46. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: Implications for radioiodine treatment. J Clin Endocrinol Metab 2009;94:1162-67
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.